In my mind, if I can find out the bacteria faster, I can de-escalate faster, then the patient gets better faster and then patient goes home faster. If the studies don’t show that, then what’s the point. And if they don’t reduce antibiotic resistance then further what’s the point?
If it's me, I would want my doctor to know I have a carbapenem-resistant GNR in 12 hours rather than 36. Does that justify big capital expenses to buy a new platform just for rapid AST? Probably not. But to recognize resistant organisms a full day earlier is enough for me to adopt -- explicitly excluding the cost consideration.
In my mind, if I can find out the bacteria faster, I can de-escalate faster, then the patient gets better faster and then patient goes home faster. If the studies don’t show that, then what’s the point. And if they don’t reduce antibiotic resistance then further what’s the point?
If it's me, I would want my doctor to know I have a carbapenem-resistant GNR in 12 hours rather than 36. Does that justify big capital expenses to buy a new platform just for rapid AST? Probably not. But to recognize resistant organisms a full day earlier is enough for me to adopt -- explicitly excluding the cost consideration.
That’s fair.